J&J halts Covid-19 vaccine trials after unexplained illness in participant

This article was originally published here

The halted trails also include the large-scale, pivotal and multi-country phase 3 ENSEMBLE trial of the company’s Covid-19 vaccine candidate called JNJ-78436735, which is being developed by Janssen

The post J&J halts Covid-19 vaccine trials after unexplained illness in participant appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply